Abstract：Objective To explore the clinical efficacy of Cetirizine Drops combined with Compound Glycyrrhizin in the treatment of pediatric allergic purpura.Methods The clinical data of 100 children patients with allergic purpura who were admitted to our hospital from January 2012 to December 2015 were analyzed retrospectively,according to the difference of treatment,all patients were divided into the western medicine group and the traditional Chinese medicine and western medicine group,50 cases in each group.The western medicine group was treated with Cetirizine Drops,the traditional Chinese medicine and Western medicine group was treated with Compound Glycyrrhizin on the basis of the western medicine group.The therapeutic effect,side effects and the level ofⅠgE,ⅠgA andⅠgG were compared between the two groups before and after intervention.Results The total effective rate of the traditional Chinese medicine and Western medicine group was higher than that of the western medicine group,with significant difference(P＜0.01).The level ofⅠgE,ⅠgA andⅠgG after intervention in the two groups was better than that before intervention,with significant difference (P＜0.05).The level ofⅠgE,ⅠgA andⅠgG after intervention in the traditional Chinese medicine and Western medicine group was better than that in the western medicine group after intervention,with significant difference(P＜0.05).There was no significant difference in the incidence rate of side effects between the two groups(P＞0.05).Conclusion Cetirizine Drops combined with Compound Glycyrrhizin has exact curative effects in the treatment of pediatric allergic purpura,which can effectively improve the clinical symptoms of children,improve the immunity,and curb the side effects, which is safe and it is worthy of clinical promotion and application.
罗佩谊 ；陈谨萍 ；林雪仪. 西替利嗪滴剂联合复方甘草酸苷治疗儿童过敏性紫癜的临床效果观察[J]. 中国当代医药, 2016, 23(30): 85-87.
LUO Pei-yi；CHEN Jin-ping；LIN Xue-yi. Observation of clinical efficacy of Cetirizine Drops combined with Compound Glycyrrhizin in the treatment of pediatric allergic purpura. 中国当代医药, 2016, 23(30): 85-87.
Mcguckin S，Westwood JP，Webster H，et al.Characterization of the complications associated with plasma exchange for thrombotic thrombocytopaenic purpura and related thrombotic microangiopathic anaemias：a single institution experience[J].Vox Sang，2014，106（2）：161-166.
[4]
Theerawatanasirikul S，Sailasuta A，Thanawongnuwech R，et al.Alterations of keratins，involucrin and filaggrin gene expression in canine atopic dermatitis[J].Res Vet Sci，2012，93（3）：1287-1292.
[5]
Kabashima-Kubo R，Nakamura M，Sakabe J，et al.A group of atopic dermatitis withoutⅠgE elevation or barrier impairment shows a high Thl frequency：possible immunological state of the intrinsic type[J].J Dermatol Sci，2012，24（3）：37-43.
[6]
O′Brien KL，Price TH，Howell，C，et al.The use of 50%albumin/plasma replacement fluid in therapeutic plasma exchange for thrombotic thrombocytopenic purpura[J].J Clin Apher，2013，28（6）：416-421.
Stefanello B，De Paula EV，Andrade Orsi F，et al.Safety and efficacy of cryoprecipitate-poor plasma as a replacement fluid for therapeutic plasma exchange in thrombotic thrombocytopenic purpura：a single center retrospective evaluation[J].J Clin Apher，2014，29（6）：311-315.
Bui T，Chandrakasan S，Poulik J，et al.Granulomatosis with polyangiitis presenting as henoch-schönlein purpura in children[J].J Clin Rheumatol，2013，19（4）：199-202.
[18]
Wang W，Luo M，Fu Y，et al.Glycyrrhizic acid nanoparticles inhibit LPS-induced inflammatory mediators in 264.7 mousemacrophagescomparedwithunprocessedglycyrrhizic acid[J].Ⅰnt J Nanomedicine，2013，8：1377-1383.
京公网安备 11010502046607号